Distinguished in Metastatic Brain Tumor

Volkmar C. Muller

Hamburg, HH, DE 
Distinguished in Metastatic Brain Tumor
Hamburg, HH, DE 
OverviewLocationsClinical Research

Overview

Volkmar Muller practices in Hamburg, Germany. Muller is rated as a Distinguished expert by MediFind in the treatment of Metastatic Brain Tumor. Their top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Triple-Negative Breast Cancer, Hepato-Pancreato-Biliary Surgery, and Mastectomy.

Their clinical research consists of co-authoring 493 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles and participated in 1 clinical trial in the study of Metastatic Brain Tumor.

Locations

Hamburg, HH, Germany
Other Locations
Hannover, NI, Germany
Frankfurt Am Main, HE, Germany
Eppendorf, HH, Germany
Mannheim, BW, Germany
Regensburg, BY, Germany
Rostock, MV, Germany
Moenchengladbach, NW, Germany
Head And Neck Surgery, Koeln, NW, Germany
Dortmund, NW, Germany
Marburg An Der Lahn, HE, Germany
Berlin, BE, Germany
Muenster, NW, Germany
Pinneberg, SH 25421, Germany
Erlangen, BY, Germany
Offenbach, HE, Germany
Goettingen, NI, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2025
Intervention Type: Drug
Study Drugs: tucatinib, T-DM1
Study Phase: Phase 3
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Enrollment Status: Completed
Publish Date: August 14, 2023
Intervention Type: Drug
Study Drugs: tucatinib, capecitabine, trastuzumab
Study Phase: Phase 2
An Exploratory Safety and Immunogenicity Study of Human Papillomavirus (HPV16+) Immunotherapy VB10.16 in Women With High Grade Cervical Intraepithelial Neoplasia (HSIL; CIN 2/3)
An Exploratory Safety and Immunogenicity Study of Human Papillomavirus (HPV16+) Immunotherapy VB10.16 in Women With High Grade Cervical Intraepithelial Neoplasia (HSIL; CIN 2/3)
Enrollment Status: Completed
Publish Date: July 13, 2022
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

493 Total Publications

AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: September 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Muller's expertise for a condition
ConditionClose
    View All 23 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile